361 related articles for article (PubMed ID: 15138551)
21. Pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.
Winarti NW; Argani P; De Marzo AM; Hicks J; Mulyadi K
Int J Surg Pathol; 2008 Jan; 16(1):66-72. PubMed ID: 18203790
[TBL] [Abstract][Full Text] [Related]
22. Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis.
Klatte T; Streubel B; Wrba F; Remzi M; Krammer B; de Martino M; Waldert M; Marberger M; Susani M; Haitel A
Am J Clin Pathol; 2012 May; 137(5):761-8. PubMed ID: 22523215
[TBL] [Abstract][Full Text] [Related]
23. Altered transcription factor E3 expression in unclassified adult renal cell carcinoma indicates adverse pathological features and poor outcome.
Mir MC; Trilla E; de Torres IM; Panizo A; Zlotta AR; Van Rhijn B; Morote J
BJU Int; 2011 Jul; 108(2 Pt 2):E71-6. PubMed ID: 21070573
[TBL] [Abstract][Full Text] [Related]
24. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.
Rao Q; Williamson SR; Zhang S; Eble JN; Grignon DJ; Wang M; Zhou XJ; Huang W; Tan PH; Maclennan GT; Cheng L
Am J Surg Pathol; 2013 Jun; 37(6):804-15. PubMed ID: 23598965
[TBL] [Abstract][Full Text] [Related]
25. Renal cell carcinoma associated with TFE3 gene fusion in an elderly woman.
LaGrange CA; Lele SM; Strup SE
Urology; 2007 Sep; 70(3):590.e11-2. PubMed ID: 17905124
[TBL] [Abstract][Full Text] [Related]
26. Translocation carcinomas of the kidney.
Argani P; Ladanyi M
Clin Lab Med; 2005 Jun; 25(2):363-78. PubMed ID: 15848741
[TBL] [Abstract][Full Text] [Related]
27. Nuclear localization and transactivating capacities of the papillary renal cell carcinoma-associated TFE3 and PRCC (fusion) proteins.
Weterman MJ; van Groningen JJ; Jansen A; van Kessel AG
Oncogene; 2000 Jan; 19(1):69-74. PubMed ID: 10644981
[TBL] [Abstract][Full Text] [Related]
28. Further characterization of the human clear cell sarcoma cell line HS-MM demonstrating a specific t(12;22)(q13;q12) translocation and hybrid EWS/ATF-1 transcript.
Sonobe H; Takeuchi T; Taguchi T; Shimizu K; Iwata J; Furihata M; Ohtsuki Y
J Pathol; 1999 Apr; 187(5):594-7. PubMed ID: 10398127
[TBL] [Abstract][Full Text] [Related]
29. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family.
Ramphal R; Pappo A; Zielenska M; Grant R; Ngan BY
Am J Clin Pathol; 2006 Sep; 126(3):349-64. PubMed ID: 16880148
[TBL] [Abstract][Full Text] [Related]
30. Renal cell carcinomas with t(6;11)(p21;q12): A clinicopathologic study emphasizing unusual morphology, novel alpha-TFEB gene fusion point, immunobiomarkers, and ultrastructural features, as well as detection of the gene fusion by fluorescence in situ hybridization.
Rao Q; Liu B; Cheng L; Zhu Y; Shi QL; Wu B; Jiang SJ; Wang Y; Wang X; Yu B; Zhang RS; Ma HH; Lu ZF; Tu P; Wang JD; Zhou XJ
Am J Surg Pathol; 2012 Sep; 36(9):1327-38. PubMed ID: 22895266
[TBL] [Abstract][Full Text] [Related]
31. Establishment and characterization of a novel myxofibrosarcoma cell line.
Kawashima H; Ogose A; Gu W; Nishio J; Kudo N; Kondo N; Hotta T; Umezu H; Tohyama T; Nishijima H; Iwasaki H; Endo N
Cancer Genet Cytogenet; 2005 Aug; 161(1):28-35. PubMed ID: 16080955
[TBL] [Abstract][Full Text] [Related]
32. Translocation carcinoma of the kidney.
Paras FA; MacLennan GT
J Urol; 2008 May; 179(5):2007. PubMed ID: 18355851
[No Abstract] [Full Text] [Related]
33. Molecular analyses of cell origin and detection of circulating tumor cells in the peripheral blood in alveolar soft part sarcoma.
Hoshino M; Ogose A; Kawashima H; Izumi T; Hotta T; Hatano H; Morita T; Otsuka H; Umezu H; Yanoma S; Tsukuda M; Endo N
Cancer Genet Cytogenet; 2009 Apr; 190(2):75-80. PubMed ID: 19380023
[TBL] [Abstract][Full Text] [Related]
34. PSF-TFE3 oncoprotein in papillary renal cell carcinoma inactivates TFE3 and p53 through cytoplasmic sequestration.
Mathur M; Das S; Samuels HH
Oncogene; 2003 Aug; 22(32):5031-44. PubMed ID: 12902986
[TBL] [Abstract][Full Text] [Related]
35. Establishment of an ASPL-TFE3 renal cell carcinoma cell line (S-TFE).
Hirobe M; Masumori N; Tanaka T; Kitamura H; Tsukamoto T
Cancer Biol Ther; 2013 Jun; 14(6):502-10. PubMed ID: 23760492
[TBL] [Abstract][Full Text] [Related]
36. Renal cell carcinoma with t(X;17)(p11.2;q25) in a 6-year-old Taiwanese boy.
Chen CK; Hsueh C; Lai JY; Hung IJ; Whang-Peng J; Wang WP; Lai HY; Chen JR
Virchows Arch; 2007 Feb; 450(2):215-9. PubMed ID: 17149613
[TBL] [Abstract][Full Text] [Related]
37. Impairment of MAD2B-PRCC interaction in mitotic checkpoint defective t(X;1)-positive renal cell carcinomas.
Weterman MA; van Groningen JJ; Tertoolen L; van Kessel AG
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13808-13. PubMed ID: 11717438
[TBL] [Abstract][Full Text] [Related]
38. Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant article.
Chen X; Yang Y; Gan W; Xu L; Ye Q; Guo H
Medicine (Baltimore); 2015 May; 94(19):e873. PubMed ID: 25984679
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical discrimination between the ASPL-TFE3 fusion proteins of alveolar soft part sarcoma.
Vistica DT; Krosky PM; Kenney S; Raffeld M; Shoemaker RH
J Pediatr Hematol Oncol; 2008 Jan; 30(1):46-52. PubMed ID: 18176180
[TBL] [Abstract][Full Text] [Related]
40. Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation.
Barroca H; Castedo S; Vieira J; Teixeira M; Müller-Höcker J
Pathol Res Pract; 2009; 205(7):466-72. PubMed ID: 19246164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
